Saturday, September 23, 2006

Giant strides!

IIPM PUBLICATION
In the business of manufacturing a spectrum of pharmaceutical products including OTCs and nutraceuticals, in dosage forms ranging from soft gel & hard gel capsules to tablets, and dry & wet injectables, the company is a significant global player in soft gelatin capsules and sterile parenterals with quality standards, which, according to them, meet the most stringent regulated market standards.They also undertake contract research and manufacturing of specialty chemicals and have recently inked a non-exclusive license and technical transfer agreement with the US-based biopharmaceutical company, Gilead Sciences. The deal will further allow them to manufacture and distribute a new generation first line therapy under the Gilead Access Programme across 90 countries. Phew!

For Complete IIPM Article, Click on IIPM Article

Source :
IIPM Editorial, 2006, Arindam Chaudhuri's Initiative

No comments: